Qiming Venture Partners led a Series B funding in MicroTech Medical, a Hangzhou diabetes medical device company. The size of the funding round was not disclosed. MicroTech offers a blood glucose monitoring system, a patch insulin pump and consumable blood strips. It aims to provide diabetics with accurate equipment at an affordable cost. Lilly Asia Ventures and China China Health Industry Investment Fund, a state-backed firm, invested in MicroTech’s initial funding.
